Show simple item record

dc.contributor.authorCastelnuovo, Barbara
dc.contributor.authorMubiru, Frank
dc.contributor.authorKiragga, Agnes N.
dc.contributor.authorMusomba, Rachel
dc.contributor.authorMbabazi, Olive
dc.contributor.authorGonza, Paul
dc.contributor.authorKambugu, Andrew
dc.contributor.authorRatanshi, Rosalind Parks
dc.date.accessioned2022-03-20T21:38:52Z
dc.date.available2022-03-20T21:38:52Z
dc.date.issued2018
dc.identifier.citationCastelnuovo, B., Mubiru, F., Kiragga, A. N., Musomba, R., Mbabazi, O., Gonza, P., ... & Ratanshi, R. P. (2018). Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda. BMJ open, 8(2), e015490.http://dx.doi.org/10.1136/bmjopen-2016-015490en_US
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/2841
dc.description.abstractLittle information is available on patients on antiretroviral treatment (ART) after a long-term period from sub-Saharan Africa, with the longest follow-up and related outcomes being after 10 years on ART. At the Infectious Diseases Institute (IDI) (Kampala, Uganda), we set up a cohort of patients already on ART for 10 years at the time of enrolment, who will be followed up for additional 10 years.en_US
dc.language.isoenen_US
dc.publisherBMJ openen_US
dc.titleAntiretroviral Treatment Long-Term (ALT) Cohort: a prospective cohort of 10 years of ART-experienced patients in Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record